Table 2.
Comparison of the pathologic findings between the OH and LH groups
| Variables | OH group (n=78) | LH group (n=29) | P value |
|---|---|---|---|
| Tumor diameter, cm | 5.8±3.0 | 5.0±2.1 | 0.177 |
| Major hepatectomy, n (%) | 50 (64.1%) | 17 (58.6%) | 0.602 |
| Tumor number, n (%) | |||
| Single | 71 (91.0%) | 26 (89.7%) | 1.000 |
| Multiple | 7 (9.0%) | 3 (10.3%) | |
| Pathological differentiation, n (%) | |||
| Poorly differentiated | 17 (21.8%) | 3 (10.3%) | 0.301 |
| Moderately differentiated | 47 (60.3%) | 22 (75.9%) | |
| Well differentiated | 14 (17.9%) | 4 (13.8%) | |
| TNM stage, n (%) | |||
| 0/IA/IB/II | 47 (60.3%) | 19 (65.5%) | 0.619 |
| IIIA/IIIB/IV | 31 (39.7%) | 10 (34.5%) | |
| Lymphatic metastasis, n (%) | 16 (20.5%) | 2 (6.9%) | 0.167 |
| Surgical margin (R0), n (%) | 72 (92.3%) | 27 (93.1%) | 1.000 |
| Satellite foci, n (%) | 7 (9.0%) | 4 (13.8%) | 0.710 |
| Microscopic perineural invasion, n (%) | 16 (20.5%) | 7 (24.1%) | 0.685 |
| Microscopic microvascular invasion, n (%) | 16 (20.5%) | 6 (20.7%) | 0.984 |
Data are presented as the mean with standard deviation (‾x±SD) or counts with percentages, n (x%)